Track Sensus Healthcare, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sensus Healthcare, Inc. SRTS Open Sensus Healthcare, Inc. in new tab

4.11 USD
P/E
50.82
EPS
-0.47
P/B
2.62
ROE
-14.85
Beta
1.30
Target Price
6.88 USD
Sensus Healthcare, Inc. logo

Sensus Healthcare, Inc.

🧾 Earnings Recap – Q3 2025

Sensus Healthcare's Q3 2025 performance showcases significant advancements, including the introduction of new CPT codes for superficial radiotherapy, which are expected to drive increased demand and enhanced reimbursement.

  • CMS has established new dedicated CPT codes for superficial radiotherapy, promising over 300% reimbursement increases per treatment fraction.
  • The company recorded a 20% growth in FDA treatment volumes from Q2, marking the third consecutive quarter of double-digit growth; total treatments rose 157% since the program's launch.
  • Sensus shipped 16 SRT systems in Q3, reaching over 900 systems sold globally, with an expectation to hit 1,000 by 2026.
  • Strong cash position increased to $24.5 million, aided by improved working capital management, positioning the company to meet anticipated demand.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 13, 2026
P/E50.82
EPS-0.47
Book Value1.57
Price to Book2.62
Debt/Equity0.98
% Insiders17.841%
Growth
Revenue Growth-0.62%
Earnings Growth4.33%
Estimates
Forward P/E64.90
Forward EPS0.06
Target Mean Price6.88

DCF Valuation

Tweak assumptions to recompute fair value for Sensus Healthcare, Inc. (SRTS)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Sensus Healthcare, Inc. Logo Sensus Healthcare, Inc. Analysis (SRTS)

United States Health Care Official Website Stock

Is Sensus Healthcare, Inc. a good investment? Sensus Healthcare, Inc. (SRTS) is currently trading at 4.11 USD. Market analysts have a consensus price target of 6.88 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 50.82. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Sensus Healthcare, Inc. is expected to release its next earnings report on May 13, 2026. The market consensus estimate for Forward EPS is 0.06.

Investor FAQ

Does Sensus Healthcare, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Sensus Healthcare, Inc.?

Sensus Healthcare, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be May 13, 2026. The company currently has a trailing EPS of -0.47.

Company Profile

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Exchange Ticker
NCM (Australia) SRTS
FRA (Germany) 5TX.F

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion